Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
about
Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic reviewResectable Cholangiocarcinoma: Reviewing the Role of Adjuvant StrategiesThe Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinomaChemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model.A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.New insights on cholangiocarcinoma.Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEAPrognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinomaClinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma.Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma.Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinomaHepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma.Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial HospitalSerum and biliary MMP-9 and TIMP-1 concentrations in the diagnosis of cholangiocarcinomaClinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma.Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management.Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma.Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases.Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis.Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver ResectionClinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinomaCholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisPrognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors.Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.Significance of mucin expression in pancreatobiliary neoplasms.Staging of intrahepatic cholangiocarcinoma.Cholangiocarcinoma: has there been any progress?STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcomeNeoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics.Emerging pharmacotherapeutic strategies for cholangiocarcinoma.Surgical outcomes of intrahepatic cholangiocarcinoma.
P2860
Q26781036-DF23F5B1-34AC-4B6E-99B4-44CE59B76256Q26849394-33BFDB8C-8A45-4AB0-BA35-8787F73B479AQ30300388-98756998-B6CB-45E8-869F-DCDC9A67CF63Q33781698-A62CC553-E723-40A0-8721-97815984BF39Q33869507-16DB85AE-9BA8-4DC4-A939-BD5A9586F741Q33977095-710D0ED2-EA51-41B3-A03D-F26321C21118Q34054823-6C8BE789-71F0-486A-83F9-BFE6CD06D7E2Q34391135-25EC80D5-341C-4932-BB44-723E359E3480Q34544953-03A80F97-64A3-4022-8726-9EF91BFD06FBQ34563366-388E5C86-9116-4724-9165-6B96D92AE3F3Q34614931-3AFFDCBD-69C7-4FE2-B219-7623565C2E2FQ34625562-42814EA2-66D6-4212-A8C7-07F3E10572B0Q34633986-AB63CDF4-0DB7-4893-9434-0619702718FDQ34732888-A27FE3FF-FB96-460E-87D7-FBF895DCC87BQ34744836-D06C8737-3BCA-4C35-A430-1E29D4B30CFCQ34775386-C7E1E8FC-98AA-4D68-860C-C1A979E91427Q34904867-8954FA64-284E-4C45-A761-0A43C3C158B0Q34986048-086AC3DF-9082-4E0F-A2E3-847AFF83C58AQ35011076-F406B7BF-B2F5-4975-9B2F-21E478466A68Q35481195-BC55447C-F95E-46DF-BD51-CA5D8497A677Q35569223-BFB0A544-7D8F-4518-978C-7D0CB3431F12Q35674607-2732F01B-700A-4ACB-816A-A3AC9A23030FQ35915338-384C4DC4-02A2-4DCA-9E2F-CA5E228ED3C4Q35971464-55929E69-1E6D-4D35-8063-2363025D804DQ36053164-7F2F8649-B047-428D-B722-55C083903FDAQ36453688-C1141D82-12C6-4769-9C51-911FEE4A7FD1Q36614705-52E87620-CFF2-4C79-B241-F57664DA2F13Q36629607-BC43566A-8CAC-4CEA-B72E-CE245AE5386AQ36900063-A6A457B0-AE47-4993-930F-36E289C0CABCQ37166422-20993BEE-7F92-48C5-AA76-AE85952F79D0Q37367418-0CBA8F20-AC32-471A-BBE8-5DF3C4E9879FQ37408964-1D347852-C430-4912-9C93-5385AC2EB0C9Q37582071-B70B86C9-8A2C-4359-B9D0-C7BF494DF4EEQ37604931-A284CA16-53D0-4625-88C9-07E46F1AD9EFQ37675065-3590D1AF-E07F-48B2-957E-47627FFCD9F0Q37698980-7A6D4094-C18D-4611-8AAD-3C0F1586CF94Q37702595-907D63AB-925F-4F6A-9A27-238FF06E0D01Q37801938-338906D2-6F09-4261-91EE-54D375C0E4BEQ37876403-0A1D7C18-C071-4F09-82B1-DAC55FDFE4D3Q37900232-7C86B81E-C3D3-4753-BC4D-D4171723AA90
P2860
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Results of surgical treatment ...... factors influencing survival.
@en
Results of surgical treatment ...... factors influencing survival.
@nl
type
label
Results of surgical treatment ...... factors influencing survival.
@en
Results of surgical treatment ...... factors influencing survival.
@nl
prefLabel
Results of surgical treatment ...... factors influencing survival.
@en
Results of surgical treatment ...... factors influencing survival.
@nl
P2093
P1476
Results of surgical treatment ...... factors influencing survival.
@en
P2093
Miyazaki M
Yoshidome H
P304
P356
10.1046/J.1365-2168.2002.02268.X
P407
P577
2002-12-01T00:00:00Z